
Exclusive: Catalent nears settlement with Elliott for board seats -sources
A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. REUTERS/Yves Herman Acquire Licensing RightsAug 29 (Reuters) – (This August 28 story has been refiled to correct the spelling of Elliott in the headline)Catalent Inc (CTLT.N) is close to reaching a settlement with activist… […]